POST Online Media Lite Edition



 

Acer Therapeutics appoints William T. Andrews as CMO

Staff Writer |
Cambridge, Mass., USA - October 6, 2017, Cambridge, Mass., USA - Acer Therapeutics, a pharmaceutical company, announced the appointment of William T. Andrews as chief medical officer.

Article continues below






Dr. Andrews has worked in the biotech/pharmaceutical industry for 17 years in both Clinical Development and Medical Affairs, and has worked in multiple therapeutic areas, with a focus and extensive experience in rare diseases.

Dr. Andrews has significant medical marketplace and product launch experience, having served as the medical lead for six product launches, including Xopenex HFA, Brovana, Alvesco, Omnaris, Catena, and Juxtapid.

Most recently, he provided strategic consulting services to rare disease companies in Clinical Development, Medical Affairs, Go-To-Market/Launch planning, and Business Development/Corporate Strategy.

Previously, Dr. Andrews held senior leadership positions and positions of increasing responsibility at Aegerion Pharmaceuticals, Santhera Pharmaceuticals, Sepracor, and ClinQuest.

Dr. Andrews received his undergraduate degree in Biology from Harvard University and his MD degree from Yale University School of Medicine.

LATEST 5 MOVES FROM Massachusetts 


What to read next

InnovaDerma appoints Ross Andrews as director
Energy Conversion Devices: William C. Andrews permanent CFO
Energy Conversion Devices names William C. Andrews interim CFO